THOMAS J. MORAN, M.D.
This content is PDF only. Please click on the PDF icon to access.
The incidence of pulmonary embolism in coronary heart disease has received increasing attention in the past few years, following the introduction of anti-coagulant therapy in thrombo-embolic disease. Adequate statistics are not yet available as to the efficacy of such therapy, due partly to the fact that relatively few reports on the autopsy incidence of pulmonary embolism in coronary heart disease have been published. Several such reports1, 2, 3 dealing with the incidence of thrombo-embolic phenomena in myocardial infarction have been quoted rather frequently as providing a logical basis for Dicumarol therapy. Other reports have dealt with the causes of death
MORAN TJ. AUTOPSY INCIDENCE OF PULMONARY EMBOLISM IN CORONARY HEART DISEASE*. Ann Intern Med. 1950;32:949–953. doi: https://doi.org/10.7326/0003-4819-32-5-949
Download citation file:
Published: Ann Intern Med. 1950;32(5):949-953.
Cardiology, Coronary Heart Disease, Emergency Medicine, Pulmonary Embolism, Pulmonary/Critical Care.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use